Biofrontera AG Stock News

Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, an international biopharmaceutical company, announces the results of the A

Now, may I hand you over to Pamela Keck, Head of Investor Relations, who will lead you through this conference. Yesterday, we issued a press release announcing financial results for the three months

NEW YORK, NY / ACCESSWIRE / May 20, 2020 / Biofrontera AG (NASDAQ:BFRA) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on May 20, 2020 at 2:00 PM Easter

Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the first quarter ended March 31,

Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or “Biofrontera”), an international biopharmaceutical company, today comments on certain litigation in California st

Leverkusen, Germany, May 12, 2020 -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing.

Biofrontera inks a new deal and announces earnings. Ascendis reports top line data from TransCon trial. Precigen will start a phase 2/3 trial in HPV.

Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the full year ended December 31,

UBS lowered the price target for The Walt Disney Company (NYSE: DIS) from $162 to $114. Disney shares closed at $106.63 on Friday. Goldman Sachs cut the price target for Booz...

Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical company, has signed today an exclusive license agreement (the

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 16.) * Abbott Laboratories (NYSE: ABT) (reacted to firs

Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports preliminary unaudited revenue for the first three months of

Leverkusen, Germany, April 16, 2020 -- The Annual General Meeting of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) shall be held on May 28, 2020. Today, the.

The following is a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 13.) * Chembio Diagnostics Inc (NASDAQ: CEMI)

Leverkusen, Germany, April 09, 2020 -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be.